Biofrontera Inc WT BFRIW

$0.03 +0.00 (1.00%)

Valuation

Market cap
—
Revenue TTM
$34,070,000
Net income TTM
$-20,130,000
PE ratio
—
Forward PE
—
Profit margin
—
Debt to equity
—

Trading

Volume
4,300
Avg volume
8,254
Day's range
$0.03 – $0.03
Shares out
—
Stochastic %K
89%
Beta
—
Analysts
Strong Sell
Price target
—

Price

Company profile

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massac...

Show more

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Phone
781 245 1325
Website
https://www.biofrontera-us.com
Address
660 Main Street, 1st Floor, Woburn, United States

Latest news